Overview
EN ISO 11979-5:2020 - "Ophthalmic implants - Intraocular lenses - Part 5: Biocompatibility" (CEN adoption of ISO 11979-5:2020) specifies requirements and guidance for the biological evaluation of materials and processing conditions used to manufacture intraocular lenses (IOLs). The standard focuses on physicochemical characterization relevant to biocompatibility and provides guidance on conducting ocular implantation tests within a risk-based framework consistent with ISO 10993 principles.
Key topics and requirements
- Scope and risk-based approach
- Applies to biocompatibility evaluation of IOL materials and production processes; aligns with ISO 10993 series and ISO 14971 risk management.
- Physicochemical tests
- Requirements for physical/chemical description, contaminants, exhaustive extraction, leachables testing, hydrolytic stability, photostability, Nd:YAG laser exposure and evaluation of insoluble inorganics.
- Emphasis on using state-of-the-art analytical methods.
- Biological tests
- Guidance for cytotoxicity, sensitization, genotoxicity, and local effects testing.
- Specifies sample preparation ratios and test sequencing aligned to ISO 10993.
- Ocular implantation test
- Normative guidance for in vivo ocular implantation tests (e.g., rabbit model) and supplemental conditions for implantation studies.
- Documentation
- Requirement for a biological evaluation plan and explicit reporting of physicochemical and biological test results.
- Updates from previous edition
- Clarified use of analytical methods, added risk-based guidance, revised test orders and durations for implantation studies, and strengthened photostability and extraction procedures.
Applications and who uses this standard
EN ISO 11979-5:2020 is essential for:
- IOL manufacturers and R&D teams - to design and validate biocompatible lens materials and document safety for regulatory submissions.
- Quality assurance and regulatory affairs - to prepare biological evaluation plans and compliance evidence for CE marking and other market clearances.
- Test laboratories and contract research organizations (CROs) - to execute physicochemical and biological test protocols (leachables, cytotoxicity, genotoxicity, ocular implantation).
- Notified bodies and regulatory authorities - to assess conformity of ophthalmic implants against biocompatibility requirements.
- Clinicians and clinical investigators - to understand safety evaluation expectations when assessing new or modified IOL designs.
Related standards
- ISO 10993 series (biological evaluation of medical devices)
- ISO 11979 series (other parts covering optics, mechanical tests, vocabulary)
- ISO 14971 (risk management)
- ISO/TR 22979 (guidance on clinical investigation needs for IOL modifications)
This standard is an authoritative reference for ensuring the biocompatibility and safety of intraocular lenses through physicochemical characterization, biological testing, and documented risk-based evaluation.
